New cholesterol jab cuts heart attack risk by 27%
A groundbreaking 'game-changer' drug, Inclisiran, has proven highly effective in reducing heart attacks and strokes in a major NHS study, offering new hope for millions with high cholesterol.
Category : Search result: Novartis
Novartis Accused of Exploiting WHO Scheme in Africa
An explosive investigation reveals how pharmaceutical giant Novartis leveraged a WHO-led initiative to push its expensive cancer drug in Nigeria and Kenya, raising serious ethical concerns about Big Pharma's role in public health.
EU probes Swiss pharma over Trump-era deals
European Union investigates Swiss pharmaceutical firms Roche and Novartis for potential antitrust violations in deals connected to Donald Trump's administration.
Trump's Cambodia and Canada remarks cause diplomatic stir
Former US President Donald Trump faces backlash after making inflammatory comments about Cambodia and Canada, reigniting debates on diplomacy and international relations.
Page 1 of 1